Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
about
Hepatocellular carcinoma and the risk of occupational exposureChronic hepatitis C: This and the new era of treatmentHepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapiesChromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomasIncreased serum mitochondrial creatine kinase activity as a risk for hepatocarcinogenesis in chronic hepatitis C patients.Adult hepatic cavernous hemangioma with highly elevated α-fetoprotein: A case report and review of the literature.Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinomaThe association between biliary tract inflammation and risk of digestive system cancers: A population-based cohort studySerum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsSystemic therapies in hepatocellular carcinoma: present and future.Rare benign tumors of the liver: still rare?Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.Solitary hepatic lymphangioma: a one-case report.Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions.
P2860
Q26750646-012B1454-16A0-4180-891A-853BE997504AQ26775011-7B7D838D-2F56-4B0F-837A-BFB92B1641CEQ33895113-ECB3850E-C0FA-4861-86EB-E218DACCDD4BQ34036884-720F2AE6-457E-4D5B-9D8F-3A1676CDBE0EQ34397639-1C6C3155-BF19-43B8-BF08-CEE7C4A4579BQ34993913-CD617E2E-E8AD-4F2C-BF59-D13C3D9B3489Q35744895-AB0FA5DF-219E-4B84-8CFB-57F3CF6C6009Q37165091-D480CD37-C477-4924-9568-4FCB964787BAQ37706763-E8B34E96-A472-494F-A3E4-45CEE2B2D056Q38150875-48FAB0AF-72EE-4662-8148-2DB58B006D2BQ38186654-8335B8DE-951B-42CF-BCBE-8DD7B73B39C4Q38397273-3CB5A762-F8AF-4A5C-8EF3-EF861D5B1F61Q39535683-85165EB8-27C5-464E-B8D7-2B96BD7A3F3AQ40661336-1AB6314F-90F1-4D73-B7D2-B96D48D66E60Q42906829-713ECDC0-4FA0-4400-9229-82E251C21E85Q55465315-D4BB3F27-4DCD-4542-A62A-71E2B07C7FAE
P2860
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@ast
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@en
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@nl
type
label
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@ast
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@en
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@nl
prefLabel
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@ast
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@en
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
Elevated serum levels of Chromogranin A in hepatocellular carcinoma.
@en
P2093
Antonio Biondi
Filippo Drago
Francesco Basile
Giulia Malaguarnera
Marco Vacante
Massimiliano Berretta
Michele Malaguarnera
Velia D'Agata
P2860
P2888
P356
10.1186/1471-2482-12-S1-S7
P478
12 Suppl 1
P577
2012-11-15T00:00:00Z
P6179
1048831358